Beneficial Effect of Taraxacum coreanum Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity

Objective. Liver kinase B (LKB) 1 and AMP-activated protein kinase (AMPK) are master regulators and sensors for energy homeostasis. AMPK is mainly activated via phosphorylation of LKB1 under energy stress. Here, we highlighted the antiobesity effect and underlying mechanism of Taraxacum coreanum Nak...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Evidence-based complementary and alternative medicine 2021, Vol.2021, p.6655599-12, Article 6655599
Hauptverfasser: Shin, Mi-Rae, Kim, Min Ju, Park, Hae-Jin, Han, Jegeun, Roh, Seong-Soo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue
container_start_page 6655599
container_title Evidence-based complementary and alternative medicine
container_volume 2021
creator Shin, Mi-Rae
Kim, Min Ju
Park, Hae-Jin
Han, Jegeun
Roh, Seong-Soo
description Objective. Liver kinase B (LKB) 1 and AMP-activated protein kinase (AMPK) are master regulators and sensors for energy homeostasis. AMPK is mainly activated via phosphorylation of LKB1 under energy stress. Here, we highlighted the antiobesity effect and underlying mechanism of Taraxacum coreanum Nakai (TCN) in connection with LKB1-AMPK signaling pathway. Methods. Male C57BL/6 mice were fed on a high-fat diet (60% kcal fat; HFD) to induce obesity. Simultaneously, they received 100 or 200 mg/kg TCN orally for 5 weeks. We measured the body weight gain and liver weight along with liver histology. Moreover, the changes of factors related to lipid metabolism and β-oxidation were analyzed in the liver, together with blood parameters. Results. The body weights were decreased in mice of the TCN200 group more than those of the HFD control group. Moreover, TCN supplementation lowered serum triglyceride (TG) and total cholesterol (TC) levels, whereas TCN increased HDL-cholesterol level. Liver pathological damage induced by HFD was alleviated with TCN treatment and accompanied with significant reduction in serum AST and ALT activities. In addition, TCN significantly increased the expression of p-AMPK compared with the HFD control group via the activation of LKB1/AMPK signaling pathway. Lipid synthesis gene like ACC was downregulated and factors related to β-oxidation such as carnitine palmitoyl transferase-1 (CPT-1) and uncoupling protein 2 (UCP-2) were upregulated through peroxisome proliferator-activated receptor (PPAR) α activation. Conclusion. Taken together, these data suggest that TCN treatment regulates lipid metabolism via LKB1-AMPK signaling pathway and promotes β-oxidation by PPARα; hence, TCN may have potential remedy in the prevention and treatment of obesity.
doi_str_mv 10.1155/2021/6655599
format Article
fullrecord <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_000616067800003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2484146878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-b38a7320bfe83c73172d3ab1a3755c2e109d70b03dd26acdd9c4e5a86b4676433</originalsourceid><addsrcrecordid>eNqNkc1vEzEQxVcIREvgxhlZ4oIES-211_ZeKqVRC6iBVqJI3KxZrzdx2Nhl7U2a_x6nCeHjgDjNk-an5_F7Wfac4LeElOVJgQtywnlZllX1IDsmgpGcFVI-PGjx9Sh7EsIC46ISQjzOjigtKalIdZwtzowzrdUWOnTetkZH5Ft0Az3cgR6WSPvegEviE3wDi1YWUJwbNNbRriBa77b49PKM5OOP15fos5056KyboWuI8zVsUCKuahNs3DzNHrXQBfNsP0fZl4vzm8n7fHr17sNkPM01YzLmNZUgaIHr1kiqBSWiaCjUBKgoS10YgqtG4BrTpik46KapNDMlSF4zLjijdJSd7nxvh3ppGm1c7KFTt71dQr9RHqz6c-PsXM38SglJWconGbzaG_T--2BCVEsbtOk6cMYPQRVMcsKwwDyhL_9CF37oUwT3FCOMy-Q6yt7sKN37EHrTHo4hWG1LVNsS1b7EhL_4_QMH-GdrCXi9A9am9m3Q1jhtDhjGmBOOuZBJ4W0e8v_piY33tU784OKvh-bWNbC2_777BzNVxEg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2484146878</pqid></control><display><type>article</type><title>Beneficial Effect of Taraxacum coreanum Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Shin, Mi-Rae ; Kim, Min Ju ; Park, Hae-Jin ; Han, Jegeun ; Roh, Seong-Soo</creator><contributor>Khanavi, Mahnaz ; Mahnaz Khanavi</contributor><creatorcontrib>Shin, Mi-Rae ; Kim, Min Ju ; Park, Hae-Jin ; Han, Jegeun ; Roh, Seong-Soo ; Khanavi, Mahnaz ; Mahnaz Khanavi</creatorcontrib><description>Objective. Liver kinase B (LKB) 1 and AMP-activated protein kinase (AMPK) are master regulators and sensors for energy homeostasis. AMPK is mainly activated via phosphorylation of LKB1 under energy stress. Here, we highlighted the antiobesity effect and underlying mechanism of Taraxacum coreanum Nakai (TCN) in connection with LKB1-AMPK signaling pathway. Methods. Male C57BL/6 mice were fed on a high-fat diet (60% kcal fat; HFD) to induce obesity. Simultaneously, they received 100 or 200 mg/kg TCN orally for 5 weeks. We measured the body weight gain and liver weight along with liver histology. Moreover, the changes of factors related to lipid metabolism and β-oxidation were analyzed in the liver, together with blood parameters. Results. The body weights were decreased in mice of the TCN200 group more than those of the HFD control group. Moreover, TCN supplementation lowered serum triglyceride (TG) and total cholesterol (TC) levels, whereas TCN increased HDL-cholesterol level. Liver pathological damage induced by HFD was alleviated with TCN treatment and accompanied with significant reduction in serum AST and ALT activities. In addition, TCN significantly increased the expression of p-AMPK compared with the HFD control group via the activation of LKB1/AMPK signaling pathway. Lipid synthesis gene like ACC was downregulated and factors related to β-oxidation such as carnitine palmitoyl transferase-1 (CPT-1) and uncoupling protein 2 (UCP-2) were upregulated through peroxisome proliferator-activated receptor (PPAR) α activation. Conclusion. Taken together, these data suggest that TCN treatment regulates lipid metabolism via LKB1-AMPK signaling pathway and promotes β-oxidation by PPARα; hence, TCN may have potential remedy in the prevention and treatment of obesity.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2021/6655599</identifier><identifier>PMID: 33531919</identifier><language>eng</language><publisher>LONDON: Hindawi</publisher><subject>AMP ; AMP-activated protein kinase ; Body weight gain ; Carnitine ; Cholesterol ; Diabetes ; Dietary supplements ; Energy ; Energy balance ; Ethanol ; Exercise ; Flavonoids ; Glycerol ; High density lipoprotein ; High fat diet ; Homeostasis ; Integrative &amp; Complementary Medicine ; Kinases ; Life Sciences &amp; Biomedicine ; Lipid metabolism ; Liver ; LKB1 protein ; Metabolism ; Methods ; Mitochondrial uncoupling protein 2 ; Obesity ; Overweight ; Oxidation ; Peroxisome proliferator-activated receptors ; Phosphorylation ; Physical fitness ; Polyclonal antibodies ; Reagents ; Science &amp; Technology ; Signal transduction ; Taraxacum ; Weight control</subject><ispartof>Evidence-based complementary and alternative medicine, 2021, Vol.2021, p.6655599-12, Article 6655599</ispartof><rights>Copyright © 2021 Mi-Rae Shin et al.</rights><rights>Copyright © 2021 Mi-Rae Shin et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2021 Mi-Rae Shin et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>7</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000616067800003</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c448t-b38a7320bfe83c73172d3ab1a3755c2e109d70b03dd26acdd9c4e5a86b4676433</citedby><cites>FETCH-LOGICAL-c448t-b38a7320bfe83c73172d3ab1a3755c2e109d70b03dd26acdd9c4e5a86b4676433</cites><orcidid>0000-0002-4283-0809 ; 0000-0002-8912-8267 ; 0000-0002-4162-6849 ; 0000-0001-5901-3242 ; 0000-0002-4365-6988</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834777/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834777/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,4025,27927,27928,27929,53795,53797</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33531919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Khanavi, Mahnaz</contributor><contributor>Mahnaz Khanavi</contributor><creatorcontrib>Shin, Mi-Rae</creatorcontrib><creatorcontrib>Kim, Min Ju</creatorcontrib><creatorcontrib>Park, Hae-Jin</creatorcontrib><creatorcontrib>Han, Jegeun</creatorcontrib><creatorcontrib>Roh, Seong-Soo</creatorcontrib><title>Beneficial Effect of Taraxacum coreanum Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity</title><title>Evidence-based complementary and alternative medicine</title><addtitle>EVID-BASED COMPL ALT</addtitle><addtitle>Evid Based Complement Alternat Med</addtitle><description>Objective. Liver kinase B (LKB) 1 and AMP-activated protein kinase (AMPK) are master regulators and sensors for energy homeostasis. AMPK is mainly activated via phosphorylation of LKB1 under energy stress. Here, we highlighted the antiobesity effect and underlying mechanism of Taraxacum coreanum Nakai (TCN) in connection with LKB1-AMPK signaling pathway. Methods. Male C57BL/6 mice were fed on a high-fat diet (60% kcal fat; HFD) to induce obesity. Simultaneously, they received 100 or 200 mg/kg TCN orally for 5 weeks. We measured the body weight gain and liver weight along with liver histology. Moreover, the changes of factors related to lipid metabolism and β-oxidation were analyzed in the liver, together with blood parameters. Results. The body weights were decreased in mice of the TCN200 group more than those of the HFD control group. Moreover, TCN supplementation lowered serum triglyceride (TG) and total cholesterol (TC) levels, whereas TCN increased HDL-cholesterol level. Liver pathological damage induced by HFD was alleviated with TCN treatment and accompanied with significant reduction in serum AST and ALT activities. In addition, TCN significantly increased the expression of p-AMPK compared with the HFD control group via the activation of LKB1/AMPK signaling pathway. Lipid synthesis gene like ACC was downregulated and factors related to β-oxidation such as carnitine palmitoyl transferase-1 (CPT-1) and uncoupling protein 2 (UCP-2) were upregulated through peroxisome proliferator-activated receptor (PPAR) α activation. Conclusion. Taken together, these data suggest that TCN treatment regulates lipid metabolism via LKB1-AMPK signaling pathway and promotes β-oxidation by PPARα; hence, TCN may have potential remedy in the prevention and treatment of obesity.</description><subject>AMP</subject><subject>AMP-activated protein kinase</subject><subject>Body weight gain</subject><subject>Carnitine</subject><subject>Cholesterol</subject><subject>Diabetes</subject><subject>Dietary supplements</subject><subject>Energy</subject><subject>Energy balance</subject><subject>Ethanol</subject><subject>Exercise</subject><subject>Flavonoids</subject><subject>Glycerol</subject><subject>High density lipoprotein</subject><subject>High fat diet</subject><subject>Homeostasis</subject><subject>Integrative &amp; Complementary Medicine</subject><subject>Kinases</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Lipid metabolism</subject><subject>Liver</subject><subject>LKB1 protein</subject><subject>Metabolism</subject><subject>Methods</subject><subject>Mitochondrial uncoupling protein 2</subject><subject>Obesity</subject><subject>Overweight</subject><subject>Oxidation</subject><subject>Peroxisome proliferator-activated receptors</subject><subject>Phosphorylation</subject><subject>Physical fitness</subject><subject>Polyclonal antibodies</subject><subject>Reagents</subject><subject>Science &amp; Technology</subject><subject>Signal transduction</subject><subject>Taraxacum</subject><subject>Weight control</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>HGBXW</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkc1vEzEQxVcIREvgxhlZ4oIES-211_ZeKqVRC6iBVqJI3KxZrzdx2Nhl7U2a_x6nCeHjgDjNk-an5_F7Wfac4LeElOVJgQtywnlZllX1IDsmgpGcFVI-PGjx9Sh7EsIC46ISQjzOjigtKalIdZwtzowzrdUWOnTetkZH5Ft0Az3cgR6WSPvegEviE3wDi1YWUJwbNNbRriBa77b49PKM5OOP15fos5056KyboWuI8zVsUCKuahNs3DzNHrXQBfNsP0fZl4vzm8n7fHr17sNkPM01YzLmNZUgaIHr1kiqBSWiaCjUBKgoS10YgqtG4BrTpik46KapNDMlSF4zLjijdJSd7nxvh3ppGm1c7KFTt71dQr9RHqz6c-PsXM38SglJWconGbzaG_T--2BCVEsbtOk6cMYPQRVMcsKwwDyhL_9CF37oUwT3FCOMy-Q6yt7sKN37EHrTHo4hWG1LVNsS1b7EhL_4_QMH-GdrCXi9A9am9m3Q1jhtDhjGmBOOuZBJ4W0e8v_piY33tU784OKvh-bWNbC2_777BzNVxEg</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Shin, Mi-Rae</creator><creator>Kim, Min Ju</creator><creator>Park, Hae-Jin</creator><creator>Han, Jegeun</creator><creator>Roh, Seong-Soo</creator><general>Hindawi</general><general>Hindawi Publishing Group</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4283-0809</orcidid><orcidid>https://orcid.org/0000-0002-8912-8267</orcidid><orcidid>https://orcid.org/0000-0002-4162-6849</orcidid><orcidid>https://orcid.org/0000-0001-5901-3242</orcidid><orcidid>https://orcid.org/0000-0002-4365-6988</orcidid></search><sort><creationdate>2021</creationdate><title>Beneficial Effect of Taraxacum coreanum Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity</title><author>Shin, Mi-Rae ; Kim, Min Ju ; Park, Hae-Jin ; Han, Jegeun ; Roh, Seong-Soo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-b38a7320bfe83c73172d3ab1a3755c2e109d70b03dd26acdd9c4e5a86b4676433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>AMP</topic><topic>AMP-activated protein kinase</topic><topic>Body weight gain</topic><topic>Carnitine</topic><topic>Cholesterol</topic><topic>Diabetes</topic><topic>Dietary supplements</topic><topic>Energy</topic><topic>Energy balance</topic><topic>Ethanol</topic><topic>Exercise</topic><topic>Flavonoids</topic><topic>Glycerol</topic><topic>High density lipoprotein</topic><topic>High fat diet</topic><topic>Homeostasis</topic><topic>Integrative &amp; Complementary Medicine</topic><topic>Kinases</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Lipid metabolism</topic><topic>Liver</topic><topic>LKB1 protein</topic><topic>Metabolism</topic><topic>Methods</topic><topic>Mitochondrial uncoupling protein 2</topic><topic>Obesity</topic><topic>Overweight</topic><topic>Oxidation</topic><topic>Peroxisome proliferator-activated receptors</topic><topic>Phosphorylation</topic><topic>Physical fitness</topic><topic>Polyclonal antibodies</topic><topic>Reagents</topic><topic>Science &amp; Technology</topic><topic>Signal transduction</topic><topic>Taraxacum</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Mi-Rae</creatorcontrib><creatorcontrib>Kim, Min Ju</creatorcontrib><creatorcontrib>Park, Hae-Jin</creatorcontrib><creatorcontrib>Han, Jegeun</creatorcontrib><creatorcontrib>Roh, Seong-Soo</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Mi-Rae</au><au>Kim, Min Ju</au><au>Park, Hae-Jin</au><au>Han, Jegeun</au><au>Roh, Seong-Soo</au><au>Khanavi, Mahnaz</au><au>Mahnaz Khanavi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beneficial Effect of Taraxacum coreanum Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><stitle>EVID-BASED COMPL ALT</stitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2021</date><risdate>2021</risdate><volume>2021</volume><spage>6655599</spage><epage>12</epage><pages>6655599-12</pages><artnum>6655599</artnum><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Objective. Liver kinase B (LKB) 1 and AMP-activated protein kinase (AMPK) are master regulators and sensors for energy homeostasis. AMPK is mainly activated via phosphorylation of LKB1 under energy stress. Here, we highlighted the antiobesity effect and underlying mechanism of Taraxacum coreanum Nakai (TCN) in connection with LKB1-AMPK signaling pathway. Methods. Male C57BL/6 mice were fed on a high-fat diet (60% kcal fat; HFD) to induce obesity. Simultaneously, they received 100 or 200 mg/kg TCN orally for 5 weeks. We measured the body weight gain and liver weight along with liver histology. Moreover, the changes of factors related to lipid metabolism and β-oxidation were analyzed in the liver, together with blood parameters. Results. The body weights were decreased in mice of the TCN200 group more than those of the HFD control group. Moreover, TCN supplementation lowered serum triglyceride (TG) and total cholesterol (TC) levels, whereas TCN increased HDL-cholesterol level. Liver pathological damage induced by HFD was alleviated with TCN treatment and accompanied with significant reduction in serum AST and ALT activities. In addition, TCN significantly increased the expression of p-AMPK compared with the HFD control group via the activation of LKB1/AMPK signaling pathway. Lipid synthesis gene like ACC was downregulated and factors related to β-oxidation such as carnitine palmitoyl transferase-1 (CPT-1) and uncoupling protein 2 (UCP-2) were upregulated through peroxisome proliferator-activated receptor (PPAR) α activation. Conclusion. Taken together, these data suggest that TCN treatment regulates lipid metabolism via LKB1-AMPK signaling pathway and promotes β-oxidation by PPARα; hence, TCN may have potential remedy in the prevention and treatment of obesity.</abstract><cop>LONDON</cop><pub>Hindawi</pub><pmid>33531919</pmid><doi>10.1155/2021/6655599</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-4283-0809</orcidid><orcidid>https://orcid.org/0000-0002-8912-8267</orcidid><orcidid>https://orcid.org/0000-0002-4162-6849</orcidid><orcidid>https://orcid.org/0000-0001-5901-3242</orcidid><orcidid>https://orcid.org/0000-0002-4365-6988</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2021, Vol.2021, p.6655599-12, Article 6655599
issn 1741-427X
1741-4288
language eng
recordid cdi_webofscience_primary_000616067800003
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection
subjects AMP
AMP-activated protein kinase
Body weight gain
Carnitine
Cholesterol
Diabetes
Dietary supplements
Energy
Energy balance
Ethanol
Exercise
Flavonoids
Glycerol
High density lipoprotein
High fat diet
Homeostasis
Integrative & Complementary Medicine
Kinases
Life Sciences & Biomedicine
Lipid metabolism
Liver
LKB1 protein
Metabolism
Methods
Mitochondrial uncoupling protein 2
Obesity
Overweight
Oxidation
Peroxisome proliferator-activated receptors
Phosphorylation
Physical fitness
Polyclonal antibodies
Reagents
Science & Technology
Signal transduction
Taraxacum
Weight control
title Beneficial Effect of Taraxacum coreanum Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T11%3A59%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beneficial%20Effect%20of%20Taraxacum%20coreanum%20Nakai%20via%20the%20Activation%20of%20LKB1-AMPK%20Signaling%20Pathway%20on%20Obesity&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Shin,%20Mi-Rae&rft.date=2021&rft.volume=2021&rft.spage=6655599&rft.epage=12&rft.pages=6655599-12&rft.artnum=6655599&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2021/6655599&rft_dat=%3Cproquest_webof%3E2484146878%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2484146878&rft_id=info:pmid/33531919&rfr_iscdi=true